Fortis Life Sciences highlights successful first year

Waltham, MA – Fortis Life Sciences, a strategic platform company providing capital, expertise and operational resources to grow founder-led life sciences companies, today announced highlights from its first year of operation. Fortis delivered strong financial performance in 2021 and significantly strengthened its business capabilities. Over the past thirteen months, the company has built a portfolio of high-quality products and brands serving attractive end markets, including diagnostics, therapeutics and discovery, through the acquisition of four complementary companies:

Bethyl Laboratories manufactures premium proprietary antibodies and custom antibody services for the life science industry.

nanoComposix specializes in ultra-sensitive and quantitative lateral flow diagnostic tests, producing nanoparticles and offering custom test development and contract manufacturing services.

Empirical bioscience produces test-grade molecular biology enzymes exclusively for diagnostic and commercial testing customers.

Arista Organic Products manufactures antibodies and other immunodiagnostic reagents for rapid diagnostic tests used in drugs of abuse, infectious diseases and fertility testing.

“We are extremely fortunate to have these companies integrated into the Fortis organization,” said Brian Kim, President and CEO of Fortis Life Sciences. “Each brings in a loyal customer base born of a reputation for exceptional products and service. As part of the Fortis platform, each will benefit from continued investment and support in the business, operational and technical infrastructure needed to help increase market awareness, reach new customers and accelerate growth. Together, we are focused on one goal: earning the trust of our customers by providing the highest quality products and services with an exceptional customer experience.

Fortis Life Sciences was founded in August 2020 by a team of life science industry veterans together with global growth equity investor Summit Partners to fill a significant gap in the life science tools market. life.

“We see many small businesses in the market with high quality products and loyal customers, but often these businesses struggle to scale,” Brian Kim noted. “Due to their size, these companies may have little knowledge of the market and lack the resources to invest in their growth. At the same time, we know of many clients who describe poor experiences working with larger, well-resourced companies that are less responsive to their needs. In creating Fortis, we saw an opportunity to reverse the script and create a world-class business, combining the customer focus, agility and innovation of a small business with the scale, capabilities and resources of a large company.

Fortis intends to continue to acquire and invest in partner companies that align with the company’s commitment to providing quality products, superior service and exceptional support while aligning with the values fundamentals of the organization: The customer first orientation, Integrity in all aspects of the business. Confidence in a responsible team, Entrepreneurship in the pursuit of innovation, and Excellency.

Previous Joplin cuts city transit services | KSNF/KODE
Next Catholic school principal disciplined for mask policy won't return